Cargando…
Structural Insights into the Unexpected Agonism of Tetracyclic Antidepressants at Serotonin Receptors 5-HT1eR and 5-HT1FR
Serotonin (5-hydroxytryptamine, 5-HT) acts via 13 different receptors in humans. Of these receptor subtypes, all but 5-HT(1e)R have confirmed roles in native tissue and are validated drug targets. Despite 5-HT(1e)R’s therapeutic potential and plausible druggability, the mechanisms of its activation...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659432/ https://www.ncbi.nlm.nih.gov/pubmed/37986777 http://dx.doi.org/10.1101/2023.10.05.561100 |
_version_ | 1785148320509853696 |
---|---|
author | Zilberg, Gregory Parpounas, Alexandra K. Warren, Audrey L. Fiorillo, Bianca Provasi, Davide Filizola, Marta Wacker, Daniel |
author_facet | Zilberg, Gregory Parpounas, Alexandra K. Warren, Audrey L. Fiorillo, Bianca Provasi, Davide Filizola, Marta Wacker, Daniel |
author_sort | Zilberg, Gregory |
collection | PubMed |
description | Serotonin (5-hydroxytryptamine, 5-HT) acts via 13 different receptors in humans. Of these receptor subtypes, all but 5-HT(1e)R have confirmed roles in native tissue and are validated drug targets. Despite 5-HT(1e)R’s therapeutic potential and plausible druggability, the mechanisms of its activation remain elusive. To illuminate 5-HT(1e)R’s pharmacology in relation to the highly homologous 5-HT(1F)R, we screened a library of aminergic receptor ligands at both receptors and observe 5-HT1e/1FR agonism by multicyclic drugs described as pan-antagonists at 5-HT receptors. Potent agonism by tetracyclic antidepressants mianserin, setiptiline, and mirtazapine suggests a mechanism for their clinically observed anti-migraine properties. Using cryoEM and mutagenesis studies, we uncover and characterize unique agonist-like binding poses of mianserin and setiptiline at 5-HT(1e)R distinct from similar drug scaffolds in inactive-state 5-HTR structures. Together with computational studies, our data suggest that these binding poses alongside receptor-specific allosteric coupling in 5-HT(1e)R and 5-HT(1F)R contribute to the agonist activity of these antidepressants. |
format | Online Article Text |
id | pubmed-10659432 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cold Spring Harbor Laboratory |
record_format | MEDLINE/PubMed |
spelling | pubmed-106594322023-11-20 Structural Insights into the Unexpected Agonism of Tetracyclic Antidepressants at Serotonin Receptors 5-HT1eR and 5-HT1FR Zilberg, Gregory Parpounas, Alexandra K. Warren, Audrey L. Fiorillo, Bianca Provasi, Davide Filizola, Marta Wacker, Daniel bioRxiv Article Serotonin (5-hydroxytryptamine, 5-HT) acts via 13 different receptors in humans. Of these receptor subtypes, all but 5-HT(1e)R have confirmed roles in native tissue and are validated drug targets. Despite 5-HT(1e)R’s therapeutic potential and plausible druggability, the mechanisms of its activation remain elusive. To illuminate 5-HT(1e)R’s pharmacology in relation to the highly homologous 5-HT(1F)R, we screened a library of aminergic receptor ligands at both receptors and observe 5-HT1e/1FR agonism by multicyclic drugs described as pan-antagonists at 5-HT receptors. Potent agonism by tetracyclic antidepressants mianserin, setiptiline, and mirtazapine suggests a mechanism for their clinically observed anti-migraine properties. Using cryoEM and mutagenesis studies, we uncover and characterize unique agonist-like binding poses of mianserin and setiptiline at 5-HT(1e)R distinct from similar drug scaffolds in inactive-state 5-HTR structures. Together with computational studies, our data suggest that these binding poses alongside receptor-specific allosteric coupling in 5-HT(1e)R and 5-HT(1F)R contribute to the agonist activity of these antidepressants. Cold Spring Harbor Laboratory 2023-10-07 /pmc/articles/PMC10659432/ /pubmed/37986777 http://dx.doi.org/10.1101/2023.10.05.561100 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator. |
spellingShingle | Article Zilberg, Gregory Parpounas, Alexandra K. Warren, Audrey L. Fiorillo, Bianca Provasi, Davide Filizola, Marta Wacker, Daniel Structural Insights into the Unexpected Agonism of Tetracyclic Antidepressants at Serotonin Receptors 5-HT1eR and 5-HT1FR |
title | Structural Insights into the Unexpected Agonism of Tetracyclic Antidepressants at Serotonin Receptors 5-HT1eR and 5-HT1FR |
title_full | Structural Insights into the Unexpected Agonism of Tetracyclic Antidepressants at Serotonin Receptors 5-HT1eR and 5-HT1FR |
title_fullStr | Structural Insights into the Unexpected Agonism of Tetracyclic Antidepressants at Serotonin Receptors 5-HT1eR and 5-HT1FR |
title_full_unstemmed | Structural Insights into the Unexpected Agonism of Tetracyclic Antidepressants at Serotonin Receptors 5-HT1eR and 5-HT1FR |
title_short | Structural Insights into the Unexpected Agonism of Tetracyclic Antidepressants at Serotonin Receptors 5-HT1eR and 5-HT1FR |
title_sort | structural insights into the unexpected agonism of tetracyclic antidepressants at serotonin receptors 5-ht1er and 5-ht1fr |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659432/ https://www.ncbi.nlm.nih.gov/pubmed/37986777 http://dx.doi.org/10.1101/2023.10.05.561100 |
work_keys_str_mv | AT zilberggregory structuralinsightsintotheunexpectedagonismoftetracyclicantidepressantsatserotoninreceptors5ht1erand5ht1fr AT parpounasalexandrak structuralinsightsintotheunexpectedagonismoftetracyclicantidepressantsatserotoninreceptors5ht1erand5ht1fr AT warrenaudreyl structuralinsightsintotheunexpectedagonismoftetracyclicantidepressantsatserotoninreceptors5ht1erand5ht1fr AT fiorillobianca structuralinsightsintotheunexpectedagonismoftetracyclicantidepressantsatserotoninreceptors5ht1erand5ht1fr AT provasidavide structuralinsightsintotheunexpectedagonismoftetracyclicantidepressantsatserotoninreceptors5ht1erand5ht1fr AT filizolamarta structuralinsightsintotheunexpectedagonismoftetracyclicantidepressantsatserotoninreceptors5ht1erand5ht1fr AT wackerdaniel structuralinsightsintotheunexpectedagonismoftetracyclicantidepressantsatserotoninreceptors5ht1erand5ht1fr |